Porex Corp. has initiated VFE testing of its porous polymer materials used in medical device filtration media to help address the spread of healthcare-associated infections (HAIs) from aerosolized viral particles. The components were able to consistently obtain a 99.9987% VFE score, showing that its materials effectively help to protect healthcare workers and patients from aerosol-based viruses potentially present in medical settings, Porex reported in a news release.
Porex shared that nearly one in 31 hospital patients acquires a HAI—and these infections lead to an estimated 99,000 annual deaths in American hospitals alone, according to the Centers for Disease Control and Prevention (CDC). Healthcare workers face risks, too.
“The pandemic has magnified what was already a pressing issue in healthcare settings around the world, which is that inadequate filtration materials put patients and professionals at risk of contracting dangerous viruses,” said Avi Robbins, vice president, global product development and R&D at Porex, in the release. “We took the step to lead the materials industry into VFE testing to validate efficacy, and we are thrilled to confirm that our filtration and venting components are trustworthy and reliable for blocking viral particle spread.”
Porex develops venting and filtration solutions by leveraging several core technology platforms such as sintered particles, bonded fiber, PTFE and Oxyphen track-etched membranes. Filtration and venting media from Porex are suitable for suction canisters, catheters, syringes, and other medical equipment utilized in aerosol-generating medical procedures.